News|Articles|April 23, 2024
Reducing Variability and Time to Results Using Automated Cell-Based Assays
Author(s)Catalent
Implementing automation involves careful optimization and fine-tuning of various parameters to ensure the accurate execution of cell-based potency assays.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
RNAnalytics’ Viktoria Enkmann Ponders Nanoparticle Characterization Advances at CPHI Frankfurt: Part One
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
